Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RECIX | 11.97 | -0.10 | -0.83% |
| RBC Emerging Markets Ex-China Equity I | |||
| PVMIX | 15.73 | -0.29 | -1.81% |
| Principal MidCap Value I Inst | |||
| VEVRX | 46.56 | -0.88 | -1.85% |
| Victory Sycamore Established Value R6 | |||
| PSVIX | 15.35 | -0.35 | -2.23% |
| Virtus NFJ Small-Cap Value Inst | |||
| MIMSX | 13.94 | -0.33 | -2.31% |
| BNY Mellon Mid Cap Multi-Strategy Inv | |||
A.I.dvisor tells us that SEPSF and VTYX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SEPSF and VTYX's prices will move in lockstep.
| Ticker / NAME | Correlation To SEPSF | 1D Price Change % | ||
|---|---|---|---|---|
| SEPSF | 100% | N/A | ||
| VTYX - SEPSF | 29% Poorly correlated | -3.01% | ||
| CLVLF - SEPSF | 25% Poorly correlated | N/A | ||
| ALGS - SEPSF | 24% Poorly correlated | -10.65% | ||
| BVAXF - SEPSF | 21% Poorly correlated | +2.56% | ||
| ALLR - SEPSF | 14% Poorly correlated | +1.44% | ||
More | ||||